DOCK4 and cancer: Our study suggests that EGFR and DOCK4-mediated RAC1 activation in response to secreted brain endothelial factors oppose this contractile phenotype, allowing cancer cells to cross the endothelium and propel themselves into the brain parenchyma (Fig. 5l).